Morepen Laboratories QIP Fund Utilization Update

Rs. 9.10 Cr QIP Funds Unutilized; Expansion Delayed to March 2027.

Reader Takeaway: Expansion delays and legal risks cloud Morepen's QIP fund utilization outlook.

What just happened

Morepen Laboratories reported that as of June 30, 2026, Rs. 9.10 crore of the Rs. 200 crore raised via Qualified Institutional Placement (QIP) in August 2024 remains unutilized. While working capital needs have been fully met, the manufacturing units at Baddi and Masulkhana have seen utilization costs of Rs. 122.79 crore, with Rs. 9.10 crore pending.

Why this matters

The QIP funds were intended for manufacturing unit expansion and working capital. Delays in the manufacturing unit upgrades, now extended to March 31, 2027, pose risks of cost overruns and impact project viability. Additionally, a significant Rs. 117.94 crore GST refund show cause notice, though currently stayed by the High Court, presents a major financial contingency. Margin compression in the API segment, a key revenue driver, adds to the concerns.

The backstory

Morepen Laboratories raised Rs. 200 crore through QIP between August 1-5, 2024. The initial plan was to utilize these funds for manufacturing unit modernization and expansion, as well as working capital requirements. The company has had to extend the project completion timelines twice.

What changes now

The completion date for the manufacturing unit modernization and expansion at Baddi and Masulkhana has been pushed to March 31, 2027. The remaining Rs. 9.10 crore is held in debt mutual funds and bank accounts. Rs. 1.50 crore was transferred from the monitoring account for local disbursements in Q1FY27.

Risks to watch

Key risks include potential cost overruns due to project delays, the outcome of the GST show cause notice, continued margin pressure in the API segment, and governance concerns raised by the Monitoring Agency regarding fund commingling.

Peer comparison

[Grounded search for peer comparison unavailable for this specific filing context]

Context metrics (time-bound)

• QIP Raised: Rs. 200.00 crore (August 1-5, 2024)
• Unutilized QIP Funds (June 30, 2026): Rs. 9.10 crore
• Manufacturing Unit Utilization (Baddi/Masulkhana): Rs. 122.79 crore
• Working Capital Utilization: Rs. 66.29 crore (fully utilized)
• GST Show Cause Notice: Rs. 117.94 crore (FY2021-FY2024)
• Project Completion Date Extended to: March 31, 2027

What to track next

Investors should monitor the progress of the manufacturing unit expansions, the resolution of the GST notice, and the performance of the API segment for potential improvements in realizations and cost management.